Published in Arterioscler Thromb Vasc Biol on March 01, 2008
Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 2.62
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood (2011) 2.38
The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood (2008) 2.22
The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost (2010) 1.73
Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood (2015) 1.45
Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis. Arterioscler Thromb Vasc Biol (2015) 1.39
Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost (2008) 1.38
Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol (2008) 1.38
Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe (2008) 1.34
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie (2010) 1.30
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26
The complex transcriptional landscape of the anucleate human platelet. BMC Genomics (2013) 1.23
Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med (2008) 1.19
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 1.15
Platelets in lung biology. Annu Rev Physiol (2012) 1.08
Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries. Adv Hematol (2012) 1.01
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis (2009) 0.99
Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin. Proteome Sci (2010) 0.98
Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med (2009) 0.97
Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases. PLoS One (2012) 0.97
Platelet mRNA: the meaning behind the message. Curr Opin Hematol (2012) 0.93
MicroRNAs in platelet function and cardiovascular disease. Nat Rev Cardiol (2015) 0.92
Are Platelets Cells? And if Yes, are They Immune Cells? Front Immunol (2015) 0.92
Immunology. Arsonists in rheumatoid arthritis. Science (2010) 0.91
New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer. J Thromb Thrombolysis (2014) 0.88
Protein degradation systems in platelets. Thromb Haemost (2013) 0.83
The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood (2014) 0.80
Regulation of the genetic code in megakaryocytes and platelets. J Thromb Haemost (2015) 0.79
Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems. PLoS One (2015) 0.79
miR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets. PLoS One (2015) 0.79
Platelets miRNA as a Prediction Marker of Thrombotic Episodes. Dis Markers (2016) 0.78
Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. Circ Cardiovasc Interv (2012) 0.78
Detection of apoptosis-associated microRNA in human apheresis platelets during storage by quantitative real-time polymerase chain reaction analysis. Blood Transfus (2014) 0.77
Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. J Thromb Haemost (2014) 0.76
Alterations in insulin-signaling and coagulation pathways in platelets during hyperglycemia-hyperinsulinemia in healthy non-diabetic subject. Thromb Res (2014) 0.75
Cancer and Thrombosis: The Platelet Perspective. Front Cell Dev Biol (2017) 0.75
Influence of Cellular Composition and Exogenous Activation on Growth Factor and Cytokine Concentrations in Canine Platelet-Rich Plasmas. Front Vet Sci (2017) 0.75
Comprehensive comparison of neonate and adult human platelet transcriptomes. PLoS One (2017) 0.75
TOR signaling in growth and metabolism. Cell (2006) 35.29
Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J (2000) 22.23
Translational control in stress and apoptosis. Nat Rev Mol Cell Biol (2005) 8.91
Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol (1995) 8.88
Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest (1985) 8.70
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Short RNAs repress translation after initiation in mammalian cells. Mol Cell (2006) 6.70
Gene-specific regulation by general translation factors. Cell (2002) 6.05
Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood (2002) 4.72
The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med (2000) 4.11
Platelets in inflammation and atherogenesis. J Clin Invest (2005) 4.10
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 4.02
Translational control by the 3'-UTR: the ends specify the means. Trends Biochem Sci (2003) 4.00
Identification of a conserved motif required for mTOR signaling. Curr Biol (2002) 3.78
A signaling pathway to translational control. Cell (1996) 3.29
The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A (2001) 3.16
Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation (2006) 2.93
mTOR, translational control and human disease. Semin Cell Dev Biol (2004) 2.77
Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39
Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol (2003) 2.37
Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics (2003) 2.25
Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 2.22
Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol (2002) 2.20
Platelets: signaling cells in the immune continuum. Trends Immunol (2004) 2.18
Translation control: bridging the gap between genomics and proteomics? Trends Biochem Sci (2001) 2.08
Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov (2003) 2.06
Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A (1998) 1.97
Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost (2003) 1.87
Human platelets synthesize and express functional tissue factor. Blood (2007) 1.85
Inflammation and thrombosis: the clot thickens. Circulation (2001) 1.79
Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest (1988) 1.63
Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity (1997) 1.56
The evolving role of platelets in inflammation. J Thromb Haemost (2003) 1.55
Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem (1987) 1.47
Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb Haemost (2001) 1.41
Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost (2004) 1.41
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci U S A (2002) 1.39
mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood (2006) 1.39
Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation (2005) 1.33
Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs. Proc Natl Acad Sci U S A (2004) 1.27
Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood (2004) 1.25
Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb Haemost (2003) 1.24
Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem (2001) 1.24
Activated platelets express IL-1 activity. J Immunol (1989) 1.24
Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol (1999) 1.21
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest (2006) 1.18
Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med (1991) 1.16
Platelets and inflammation. Anat Embryol (Berl) (1997) 1.15
Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood (1993) 1.14
Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J Exp Med (2004) 1.13
Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proc Natl Acad Sci U S A (2001) 1.12
Protein synthesis by human platelets. J Biol Chem (1967) 1.11
Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost (2006) 1.10
Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood (1998) 1.10
p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol (1994) 1.06
Regulation of local mRNA translation. Curr Opin Cell Biol (2004) 1.06
De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res (2006) 1.05
Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med (2006) 1.05
Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun (1989) 1.01
Molecular regulation of platelet-dependent thrombosis. Circulation (2005) 1.01
Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest (2004) 0.97
Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells. Trends Cardiovasc Med (2005) 0.96
Studies on human platelets. I. synthesis of platelet protein in a cell-free system. Biochim Biophys Acta (1968) 0.96
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest (1997) 0.93
In vitro incorporation of amino-acids into the contractile protein of human blood platelets. Nature (1967) 0.92
Protein synthesis by human blood platelets after accumulation of leucine and arginine. Thromb Diath Haemorrh (1972) 0.92
Studies on human platelets. II. Protein synthetic activity of various platelet populations. Biochim Biophys Acta (1968) 0.90
Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets (2007) 0.90
Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol (1971) 0.89
Functional tetrahydrobiopterin synthesis in human platelets. Circulation (2004) 0.89
Expression of translation initiation factors elF-4E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost (2001) 0.88
Splicing misplaced. Cell (2005) 0.88
Misregulated posttranscriptional checkpoints: inflammation and tumorigenesis. J Exp Med (2001) 0.88
Protein synthesis in aging blood platelets. Blood (1969) 0.87
Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochim Biophys Acta (1967) 0.87
Identification and structure of activated-platelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets. Eur J Biochem (1997) 0.86
Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. J Am Coll Cardiol (2002) 0.83
Extracellular factors influencing the in vitro protein synthesis of platelets. Thromb Haemost (1979) 0.83
Studies on human platelets. IV. Protein synthesis in maturing human platelets. Thromb Diath Haemorrh (1971) 0.80
Protein synthesis in human platelets correlation with platelet size. Nouv Rev Fr Hematol (1982) 0.79
Evaluating the relevance of the platelet transcriptome. Blood (2003) 0.79
Platelets give us many messages. Thromb Haemost (2003) 0.76
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 4.02
Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood (2009) 3.90
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood (2011) 3.37
Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 2.62
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood (2011) 2.38
Anucleate platelets generate progeny. Blood (2010) 2.24
Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res (2002) 2.10
Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood (2010) 2.10
VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock. Chest (2015) 1.99
Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 1.74
Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog (2011) 1.64
Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood (2013) 1.64
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol (2006) 1.47
Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet (2011) 1.47
Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost (2013) 1.39
Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol (2008) 1.38
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie (2010) 1.30
Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs. Proc Natl Acad Sci U S A (2004) 1.27
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26
Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet (2013) 1.23
Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol (2003) 1.19
Coordinate expression of transcripts and proteins in platelets. Blood (2013) 1.18
Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles. J Biol Chem (2003) 1.18
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest (2006) 1.18
Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J Exp Med (2004) 1.13
T granules in human platelets function in TLR9 organization and signaling. J Cell Biol (2012) 1.13
Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog (2011) 1.11
Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis. J Lipid Res (2007) 1.04
Cationic PAMAM dendrimers aggressively initiate blood clot formation. ACS Nano (2012) 0.99
RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest (2015) 0.99
A yeast PAF acetylhydrolase ortholog suppresses oxidative death. Free Radic Biol Med (2008) 0.98
In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest (2012) 0.98
Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells. Trends Cardiovasc Med (2005) 0.96
Platelet mRNA: the meaning behind the message. Curr Opin Hematol (2012) 0.93
Proteasome function is required for platelet production. J Clin Invest (2014) 0.93
Lessons from rare maladies: leukocyte adhesion deficiency syndromes. Curr Opin Hematol (2013) 0.92
Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Ann N Y Acad Sci (2010) 0.92
Immunology. Arsonists in rheumatoid arthritis. Science (2010) 0.91
Cationic PAMAM dendrimers disrupt key platelet functions. Mol Pharm (2012) 0.90
Endothelial cell confluence regulates cyclooxygenase-2 and prostaglandin E2 production that modulate motility. J Biol Chem (2004) 0.89
Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res (2011) 0.88
Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation (2002) 0.88
Translational control in endothelial cells. J Vasc Surg (2007) 0.88
PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids. Blood (2009) 0.85
Ceramide generation in situ alters leukocyte cytoskeletal organization and beta 2-integrin function and causes complete degranulation. J Biol Chem (2001) 0.84
Platelets as central mediators of systemic inflammatory responses. Thromb Res (2010) 0.84
Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury. Biochim Biophys Acta (2006) 0.83
Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood (2012) 0.83
Fluid flow regulates E-selectin protein levels in human endothelial cells by inhibiting translation. J Vasc Surg (2003) 0.82
Integrin alphaDbeta2 is dynamically expressed by inflamed macrophages and alters the natural history of lethal systemic infections. J Immunol (2008) 0.81
Platelet precursors display bipolar behavior. J Cell Biol (2010) 0.81
Targeting phosphodiesterases in anti-platelet therapy. Handb Exp Pharmacol (2012) 0.81
Leukocyte adhesion deficiency-I variant syndrome (LAD-Iv, LAD-III): molecular characterization of the defect in an index family. Am J Hematol (2011) 0.80
Fibrinogen selects selectins. Blood (2009) 0.80
Evaluating the relevance of the platelet transcriptome. Blood (2003) 0.79
Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel) (2011) 0.79
Assessing protein synthesis by platelets. Methods Mol Biol (2012) 0.79
Translational control of JunB, an AP-1 transcription factor, in activated human endothelial cells. J Cell Biochem (2013) 0.77
A sticky story for signal transducer and activator of transcription 3 in platelets. Circulation (2012) 0.77
Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation. Chem Biol (2013) 0.77
A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS. Shock (2016) 0.76
Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation. J Clin Invest (2016) 0.76
Different mechanisms preserve translation of programmed cell death 8 and JunB in virus-infected endothelial cells. Arterioscler Thromb Vasc Biol (2012) 0.75
TGFBIp: more than meets the eye? Blood (2009) 0.75
Polyubiquinated protein depots in platelets and megakaryocytes from patients with ANKRD26-RT. Thromb Haemost (2013) 0.75
Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO J (2014) 0.75
Reply to Schattner. Circ Res (2013) 0.75
Superoxide Dismutase 2 is dispensable for platelet function. Thromb Haemost (2017) 0.75
Deletion of GLUT1 and GLUT3 Reveals Multiple Roles for Glucose Metabolism in Platelet and Megakaryocyte Function. Cell Rep (2017) 0.75
Pegasparaginase treatment alters thrombin generation by modulating the protein C and S system in acute lymphoblastic leukaemia/lymphoma. Blood Coagul Fibrinolysis (2015) 0.75